Osteosarcoma: a review of diagnosis, management, and treatment strategies.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical advances in hematology & oncology : H&O

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  PMID 21317869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• mTOR/p70S6K Signal transduction pathway contributes to osteosarcoma progression and patients’ prognosis

  2010cited by this paper
• Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study.

  2010cited by this paper
• International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons

  2009cited by this paper
• The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma.

  2009cited by this paper
• Osteosarcoma in the elderly over 60 years: A multicenter study by the Japanese musculoskeletal oncology group

  2009cited by this paper
• Osteosarcoma incidence and survival rates from 1973 to 2004

  2009cited by this paper
• 18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma

  2009cited by this paper
• Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.

  2009cited by this paper
• Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma

  2009cited by this paper
• Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

  2008cited by this paper
• Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program

  2008cited by this paper
• Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

  2008cited by this paper
• A review of clinical and molecular prognostic factors in osteosarcoma

  2008cited by this paper
• Complexities in interpretation of osteosarcoma clinical trial results.

  2008cited by this paper
• A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: A Children's Oncology Group study

  2008cited by this paper
• Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF‐1 receptor by the pediatric preclinical testing program

  2008cited by this paper
• Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing program

  2008cited by this paper
• Survival results with AP23573, a novel mTOR inhibitor, in patients (pts) with advanced soft tissue or bone sarcomas: Update of phase II trial

  2007cited by this paper
• Phase II Trial of Pralatrexate (10-Propargyl-10-deazaaminopterin, PDX) in Patients with Unresectable Malignant Pleural Mesothelioma

  2007cited by this paper
• Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid Tumors

  2007cited by this paper
• Secondary sarcomas in childhood cancer survivors: a report from the Childhood Cancer Survivor Study.

  2007cited by this paper
• Post Operative Infection and Increased Survival in Osteosarcoma Patients: Are They Associated?

  2007cited by this paper
• Phase Ib/IIa study of sustained release lipid inhalation targeting cisplatin by inhalation in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung

  2007cited by this paper
• Clinicopathologic features of osteosarcoma in patients with Rothmund-Thomson syndrome.

  2007cited by this paper
• Updated results of a phase II trial of AP23573, a novel mTOR inhibitor, in patients (pts) with advanced soft tissue or bone sarcomas.

  2006cited by this paper
• Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma.

  2006cited by this paper
• Computed tomographic scan of the chest underestimates the number of metastatic lesions in osteosarcoma.

  2006cited by this paper
• Accurate diagnosis of musculoskeletal lesions by core needle biopsy

  2006cited by this paper
• ACCURACY OF COMPUTED TOMOGRAPHY GUIDED CORE NEEDLE BIOPSY OF MUSCULOSKELETAL TUMOURS

  2005cited by this paper
• The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li–Fraumeni-like kindreds

  2005cited by this paper
• Treatment of osteosarcoma at first recurrence after contemporary therapy

  2005cited by this paper
• Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.

  2005cited by this paper
• Paget’s Sarcoma: A Historical and Outcome Review

  2005cited by this paper
• Investigation of the effect of pamidronate disodium on the in vitro viability of osteosarcoma cells from dogs.

  2005cited by this paper
• Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).

  2005cited by this paper
• Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.

  2004cited by this paper
• Prognostic Significance of Serum Lactate Dehydrogenase in Osteosarcoma of the Extremity: Experience at Rizzoli on 1421 Patients Treated over the Last 30 Years

  2004cited by this paper
• Alendronate regulates cell invasion and MMP‐2 secretion in human osteosarcoma cell lines

  2004cited by this paper
• Radiation Improves the Distribution and Uptake of Liposomal Doxorubicin (Caelyx) in Human Osteosarcoma Xenografts

  2004cited by this paper
• Dysregulation of the TSC-mTOR pathway in human disease

  2004cited by this paper
• Stature of young people with malignant bone tumors

  2004cited by this paper
• Allografts about the Knee in Young Patients with High-Grade Sarcoma

  2004cited by this paper
• Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.

  2003cited by this paper
• Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas.

  2003cited by this paper
• IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation.

  2003cited by this paper
• Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*

  2003cited by this paper
• Ifosfamide in Pediatric Solid Tumors

  2003cited by this paper
• Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates.

  2003cited by this paper
• Osteosarcoma over the age of forty.

  2003cited by this paper
• Osteosarcoma necrosis following chemotherapy: innate biology versus treatment-specific.

  2003cited by this paper
• 10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

  2003cited by this paper
• Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.

  2002cited by this paper
• Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions

  2002cited by this paper
• Diagnosis of primary bone tumors with image-guided percutaneous biopsy: experience with 110 tumors.

  2002cited by this paper
• Clinical manifestations in a cohort of 41 Rothmund-Thomson syndrome patients.

  2001cited by this paper
• Inheritance of osteosarcoma and Paget's disease of bone: a familial loss of heterozygosity study.

  2001cited by this paper
• Malignant bone tumors.

  2001cited by this paper
• Factors Affecting Nonunion of the Allograft-Host Junction

  2001cited by this paper
• Platelet-Derived Growth Factor-AA and -α Receptor Expression Suggests an Autocrine and/or Paracrine Loop in Osteosarcoma

  2000cited by this paper
• A prospective study of plasma levels of insulin-like growth factor I (IGF-I) and IGF-binding protein-3, and colorectal cancer risk among men.

  2000cited by this paper
• Second malignant neoplasms after cancer in childhood and adolescence: A population‐based case‐control study in the 5 nordic countries

  2000cited by this paper
• Type-B-IIIa Hip Rotationplasty: An Alternative Operation for the Treatment of Malignant Tumors of the Femur in Early Childhood*

  2000cited by this paper
• Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report.

  2000cited by this paper
• Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3

  1999cited by this paper
• Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995.

  1999cited by this paper
• Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.

  1999cited by this paper
• Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

  1999cited by this paper
• Mechanisms of methotrexate resistance in osteosarcoma.

  1999cited by this paper
• Rotationplasty in skeletally immature patients. Long-term followup results.

  1999cited by this paper
• Genetic and functional studies of a germline TP53 splicing mutation in a Li–Fraumeni-like family

  1998cited by this paper
• Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study.

  1998cited by this paper
• Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs.

  1998cited by this paper
• Cancer incidence after retinoblastoma: radiation dose and sarcoma risk.

  1998cited by this paper
• Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood

  1998cited by this paper
• Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy.

  1997cited by this paper
• The cost-effectiveness of limb salvage for bone tumours.

  1997cited by this paper
• Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma.

  1996cited by this paper
• Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer.

  1996cited by this paper
• The Hazards of the Biopsy, Revisited. For the Members of the Musculoskeletal Tumor Society*

  1996cited by this paper
• Systemic relapse of patients with osteogenic sarcoma. Prognostic factors for long term survival

  1995cited by this paper
• Incidence of cancer in children in the United States. Sex‐, race‐, and 1‐year age‐specific rates by histologic type

  1995cited by this paper
• Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.

  1994cited by this paper
• Complications and surgical indications in 144 cases of nonmetastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy.

  1993cited by this paper
• Malignant transformation in paget disease of bone

  1992cited by this paper
• Bone sarcomas as second malignant neoplasms following childhood cancer

  1991cited by this paper
• Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study.

  1991cited by this paper
• [Adjuvant chemotherapy of osteosarcoma].

  1990cited by this paper
• Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation

  1990cited by this paper
• Increased tyrosine kinase activity associated with the protein encoded by the activated neu oncogene.

  1988cited by this paper
• The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities.

  1987cited by this paper
• Bone sarcomas linked to radiotherapy and chemotherapy in children.

  1987cited by this paper
• A system of staging musculoskeletal neoplasms.

  1986cited by this paper
• The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

  1986cited by this paper
• Osteogenic sarcoma of bones and soft tissues in older persons. A clinicopathologic analysis of 117 patients older than 60 years

  1986cited by this paper
• Species variability for toxicity of free and liposome-encapsulated muramyl peptides administered intravenously.

  1985cited by this paper
• Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.

  1984cited by this paper
• Prognostic significance of alkaline phosphatase measurements in patients with osteogenic sarcoma receiving chemotherapy

  1979cited by this paper
• Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.

  1977cited by this paper
• Stature and malignant tumors of bone in childhood and adolescence

  1967cited by this paper
• SARCOMATA OF THE OSTEOGENIC SERIES (OSTEOSARCOMA, FIBROSARCOMA, CHONDROSARCOMA, PAROSTEAL OSTEOGENIC SARCOMA, AND SARCOMATA ARISING IN ABNORMAL BONE). AN ANALYSIS OF 552 CASES.

  1966cited by this paper

• Concurrent Polyostotic Fibrous Dysplasia and Osteosarcoma: A Diagnostic Dilemma in the Era of FDG PET/CT Imaging

  2026cites this paper
• Anticancer Molecular Mechanisms of Curcuminoids: An Updated Review of Clinical Trials

  2026cites this paper
• Effective serum concentration of high-dose methotrexate therapy for osteosarcoma with dose adjustment for pharmacokinetic parameters: a retrospective study

  2025cites this paper
• Hellebrigenin Induces Apoptosis and Inhibits PI3K/AKT-Mediated Inflammation and Metastasis in Human Osteosarcoma Cells

  2025influential citation
• Cluster of differentiation 133 (CD133) and C-X-C chemokine receptor 4 (CXCR4) associated with the incidence of metastasis in osteosarcoma patients

  2025cites this paper
• Silencing long non‐coding RNA linc00689 suppresses the growth and invasion of osteosarcoma cells by targeting miR‐129‐5p/NUSAP1

  2025cites this paper
• Implementation of artificial intelligence in detection, classification, and prognostication of osteosarcoma utilizing different assessment techniques: a systematic review

  2025cites this paper
• Long-term survival in osteosarcoma patient: A 21-year follow-up after limb-salvage surgery and custom prosthesis reconstruction

  2025cites this paper
• Comprehensive Analysis of Osteosarcoma Referral Letters: Insights into Medical Collaboration and Diagnostic Practices at Our Hospital

  2025cites this paper
• Radiomics-based machine learning in prediction of response to neoadjuvant chemotherapy in osteosarcoma: A systematic review and meta-analysis.

  2025cites this paper
• Understanding the role of vitamin D in osteosarcoma: A narrative review

  2025influential citation
• Comparison of Differentially Expressed Genes in Human and Canine Osteosarcoma

  2025cites this paper
• Multi-transcriptomics analysis of ferroptosis related genes reveals CAFs exosomal COX4I2 as a novel therapeutic target in osteosarcoma

  2025cites this paper
• Identification of endothelial INSR as an osteosarcoma-related biomarker and therapeutic target based on weighted gene co-expression network analysis

  2025cites this paper
• Research on the application of a multi-model cascaded deep learning framework in the pathological diagnosis of osteosarcoma

  2025cites this paper
• DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway

  2025cites this paper
• Malignant and Bony Tumors of the Pediatric Hand: A Review of Diagnosis and Treatment Strategies

  2025cites this paper
• SATB2 immunohistochemistry in osteosarcoma: Utility in diagnosis and differentiation from histologic mimics.

  2025cites this paper
• Theaflavin-3,3′-digallate triggers apoptosis in osteosarcoma cells via the caspase pathway

  2025cites this paper
• Building a Therapeutic Bridge Between Dogs and Humans: A Review of Potential Cross-Species Osteosarcoma Biomarkers

  2025cites this paper
• Pharmacologic inhibition of CSF-1R suppresses intrinsic tumor cell growth in osteosarcoma with CSF-1R overexpression

  2025cites this paper
• Iron oxide nanoparticles coated with bioactive materials: a viable theragnostic strategy to improve osteosarcoma treatment

  2025cites this paper
• Inhibition of circ_0127646 Enhanced the Cisplatin Sensitivity in Osteosarcoma Cells via miR‐22/KAT6B Axis

  2025cites this paper
• Osteosarcoma: A Comprehensive Morphological and Molecular Review with Prognostic Implications

  2025cites this paper
• Novel Oncologic Strategies in Osteosarcoma Management: Maximizing Impact, Minimizing Harm

  2025cites this paper
• The Burgeoning Significance of Liquid-Liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers

  2024cites this paper
• Extracellular Vesicles from Highly Metastatic Osteosarcoma Cells Induce Pro‐Tumorigenic Macrophage Phenotypes

  2024cites this paper
• Large-Scale assessment of ChatGPT's performance in benign and malignant bone tumors imaging report diagnosis and its potential for clinical applications

  2024cites this paper
• Treatment-naïve Primary Osteosarcoma's Cellular and Molecular Heterogeneity is Revealed by Single-cell Rna Sequencing in Canines

  2024cites this paper
• Clinical Consequences of Unreconstructed Pelvic Defect Caused by Osteosarcoma with Subsequent Progressive Scoliosis in a Pediatric Patient—Case Report

  2024cites this paper
• Discovery of potent thiazolidin-4-one sulfone derivatives for inhibition of proliferation of osteosarcoma in vitro and in vivo.

  2024cites this paper
• Meta-analysis of 65 Adamantinoma case reports: Unveiling symptomatology, demographics, and treatment outcomes in contrast to prior understandings.

  2024cites this paper
• Inhibition of osteosarcoma metastasis in vivo by targeted downregulation of MMP1 and MMP9.

  2024cites this paper
• The Role of Adenosine in Overcoming Resistance in Sarcomas

  2024cites this paper
• Osteomyelitis Tuberculosis in long bone mimicking bone malignancy: A case report

  2024cites this paper
• Automated Texture Feature Based Bone Tumor Segmentation and Image Analysis Using Supervised Machine Learning

  2024cites this paper
• Macrophage and osteosarcoma cell crosstalk is dependent on oxygen tension and 3D culture.

  2024cites this paper
• Successful treatment of osteosarcoma in a pregnant woman with survival of the gestational product: A case report and literature review

  2024cites this paper
• AI based diagnostics product design for osteosarcoma cells microscopy imaging of bone cancer patients using CA-MobileNet V3

  2024cites this paper
• Extracellular matrix production and oxygen diffusion regulate chemotherapeutic response in osteosarcoma spheroids

  2024cites this paper
• The efficacy of gemcitabine and docetaxel chemotherapy for the treatment of relapsed and refractory osteosarcoma: A systematic review and pre‐clinical study

  2024cites this paper
• Tissue-engineered patient-derived osteosarcoma models dissecting tumour-bone interactions

  2024cites this paper
• Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening

  2023cites this paper
• Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma—A Narrative Review

  2023cites this paper
• Advanced nanoparticles, the hallmark of targeted drug delivery for osteosarcoma-an updated review

  2023cites this paper
• Application of CNN and Recurrent Neural Network Method for Osteosarcoma Bone Cancer Detection

  2023cites this paper
• A pilot exome sequencing study suggests that germline variants influence methotrexate‐induced toxicities in pediatric patients with localized osteosarcoma

  2023cites this paper
• A risk score model based on endoplasmic reticulum stress related genes for predicting prognostic value of osteosarcoma

  2023cites this paper
• A Hybrid Approach to Osteosarcoma Detection Using Densenet201-SVM Model

  2023cites this paper
• A Novel Hybrid Approach for Classifying Osteosarcoma Using Deep Feature Extraction and Multilayer Perceptron

  2023cites this paper
• The Effects of Resveratrol Targeting MicroRNA-4325P/PDGF-B to Regulate Tumor Angiogenesis in Osteosarcoma Microenvironment

  2023cites this paper
• Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor

  2023cites this paper
• The Role of FAS Receptor Methylation in Osteosarcoma Metastasis

  2023cites this paper
• Circ_UBAP2 exacerbates proliferation and metastasis of OS via targeting miR‐665/miR‐370‐3p/HMGA1 axis

  2023cites this paper
• Osteosarcoma: Current Concepts and Evolutions in Management Principles

  2023cites this paper
• DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway

  2023cites this paper
• Dual responsive hydroxyapatite capped mesoporous silica nanoparticles for controlled delivery of Palbociclib to treat osteosarcoma

  2023cites this paper
• Cellular Transcriptomics of Carboplatin Resistance in a Metastatic Canine Osteosarcoma Cell Line

  2023cites this paper
• Targeting RNA Polymerase I Transcription Activity in Osteosarcoma: Pre-Clinical Molecular and Animal Treatment Studies

  2023cites this paper
• 3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma

  2023cites this paper
• Evaluation of the Effect of Photodynamic Therapy on CAM-Grown Sarcomas

  2023cites this paper
• Surgical margin assessment of bone tumours: A systematic review of current and emerging technologies

  2023cites this paper
• 18F-FDG PET/CT in the Management of Osteosarcoma

  2023cites this paper
• Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling

  2023cites this paper
• Chemotherapy Regimens for Non-Metastatic Conventional Appendicular Osteosarcoma: A Literature Review Based on the Outcomes

  2023cites this paper
• Identification and Analysis of Transcriptional Regulatory Networks of Osteosarcoma Microarray Data via Systems Biology.

  2022cites this paper
• Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study

  2022cites this paper
• In vivo imaging of nanoparticle-labeled CAR T cells

  2022cites this paper
• Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression

  2022cites this paper
• Canine osteosarcoma cells exhibit basal accumulation of multiple chaperone proteins and are sensitive to small molecule inhibitors of GRP78 and heat shock protein function

  2022influential citation
• Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration

  2022cites this paper
• HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway

  2022cites this paper
• T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma.

  2022cites this paper
• Lipid-Based Nano-Sized Cargos as a Promising Strategy in Bone Complications: A Review

  2022cites this paper
• Non-invasive intravoxel incoherent motion MRI in prediction of histopathological response to neoadjuvant chemotherapy and survival outcome in osteosarcoma at the time of diagnosis

  2022cites this paper
• Osteogenesis in the presence of chemotherapy: A biomimetic approach

  2022cites this paper
• Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization

  2022cites this paper
• Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade

  2022cites this paper
• Hemophagocytic Lymphohistiocytosis as a complication of immune checkpoint inhibitor therapy for sarcoma

  2022cites this paper
• A deep belief network-based clinical decision system for patients with osteosarcoma

  2022cites this paper
• Delivery of mGluR5 siRNAs by Iron Oxide Nanocages by Alternating Magnetic Fields for Blocking Proliferation of Metastatic Osteosarcoma Cells

  2022cites this paper
• EBF1-mediated up-regulation of lncRNA FGD5-AS1 facilitates osteosarcoma progression by regulating miR-124-3p/G3BP2 axis as a ceRNA

  2022cites this paper
• CircSRSF4 Enhances Proliferation, Invasion, and Migration to Promote the Progression of Osteosarcoma via Rac1

  2022cites this paper
• Development and validation of apoptosis‐related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients

  2022cites this paper
• A Case of Primary Osteosarcoma of the Mandible That Responded to Preoperative Chemotherapy: p16 as a Potential Prognostic Factor.

  2022cites this paper
• Extracellular Vesicles: A New Source of Biomarkers in Pediatric Solid Tumors? A Systematic Review

  2022cites this paper
• Transcriptomic Analysis of Canine Osteosarcoma from a Precision Medicine Perspective Reveals Limitations of Differential Gene Expression Studies

  2022influential citation
• Clinical Outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based Clinical Review.

  2022cites this paper
• Anti-tumor effects of cryptotanshinone (C19H20O3) in human osteosarcoma cell lines.

  2022cites this paper
• Osteosarcoma/Ewing Sarcoma.

  2022cites this paper
• Recent and Ongoing Research into Metastatic Osteosarcoma Treatments

  2022cites this paper
• CircNRIP1 acts as a sponge of miR-1200 to suppress osteosarcoma progression via upregulation of MIA2.

  2022cites this paper
• MicroRNA-5582-3p alleviates the progression of osteosarcoma via targeting FZD4

  2022cites this paper
• Biochemical and Cellular Characterization of New Radio-Resistant Cell Lines Reveals a Role of Natural Flavonoids to Bypass Senescence

  2021cites this paper
• Osteosarcoma of the jaw: Report of four cases

  2021cites this paper
• Riluzole-induced apoptosis in osteosarcoma is mediated through Yes-associated protein upon phosphorylation by c-Abl Kinase

  2021cites this paper
• Tumor-Infiltrating Lymphocytes and Cancer Markers in Osteosarcoma: Influence on Patient Survival

  2021cites this paper
• Osteosarcoma from the unknown to the use of exosomes as a versatile and dynamic therapeutic approach.

  2021cites this paper
• Kinesin superfamily proteins: roles in osteosarcoma.

  2021cites this paper
• Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial

  2021cites this paper